BioSpace News Archive

Business

Denmark’s SNIPR Biome Launches to Merge CRISPR With the Microbiome

The company’s proprietary CRISPR-Cas tech platform is used to selectively and precisely eradicate target bacterial, but still leave the patient’s microbial community alone.

March 11, 2019
·
2 min read
·
Mark Terry
Drug Development

AMAG’s PROLONG Trial Fails to Hit Endpoints in Preventing Preterm Births

Shares of AMAG Pharmaceuticals plunged more than 17 percent Friday after the company said its Phase III PROLONG trial of Makena failed to demonstrate a statistically significant difference from placebo in preventing preterm births.

March 11, 2019
·
2 min read
·
Alex Keown
AiCuris nominated for “Deutscher Innovationspreis 2019”

AiCuris Anti-infective Cures GmbH is one of three companies nominated for the “Deutscher Innovationspreis 2019” in the category Medium-Sized Enterprises

March 11, 2019
·
7 min read
Drug Development

TLC Reports Positive Top-Line Results from Phase I/II Clinical Trial of TLC590 for Postsurgical Pain

TLC590 demonstrated durable, statistically significant and clinically meaningful improvement over the standard of care through 96 hours

March 11, 2019
·
6 min read
Drug Development

Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal

Auris Medical Holding AG announced the publication of an article that presents and discusses in detail the outcomes from the HEALOS Phase 3 trial with AM-111, Auris Medical’s investigational treatment for acute inner ear hearing loss.

March 11, 2019
·
6 min read
Drug Development

Axovant Releases Positive Interim Updates for Parkinson’s and Tay-Sachs Gene Therapy Trials

Axovant has been busy, releasing interim results from two different clinical trials, one for Tay-Sachs, the other for Parkinson’s disease.

March 11, 2019
·
3 min read
·
Mark Terry
Deals

Bristol-Myers Squibb Going All out to Sell Celgene Deal

On Friday, March 8, Bristol-Myers Squibb executives met with sell-side analysts to sell its $74 billion Celgene buyout.

March 11, 2019
·
3 min read
·
Mark Terry
Medicen Paris Region supports four out of eight healthcare winners in second edition of French government’s Innovation Challenge

These four SMEs will receive a total of over €2 million to finance their projects spanning artificial intelligence in radiology, early diagnosis of cancer, telemedicine for heart failure patients and prediction of acute episodes in cystic fibrosis

March 11, 2019
·
6 min read
Biotech Bay

Ultragenyx to Present at Upcoming March 2019 Investor Conferences

Ultragenyx Pharmaceutical Inc. today announced that it will present at the following upcoming investor conferences:

March 11, 2019
·
1 min read
Business

GeoVax Provides Product Development and Corporate Update

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies using its novel viral vector platform technology, provided an update on its progress and development programs.

March 11, 2019
·
7 min read